SynthesisOncology reviews2026

Comparative efficacy of subsequent-line therapies for advanced triple-negative breast cancer: a bayesian network meta-analysis.

Zheng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.